Cocrystal Pharma (COCP) EPS (Diluted) Growth (3y) (2014 - 2026)
Cocrystal Pharma (COCP) EPS (Diluted) Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 78.99% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 37.28% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 14.39% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -2.00% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 83.94% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | 35.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.62% |
| Dec 31, 2025 | 22.27% |
| Sep 30, 2025 | 32.89% |
| Jun 30, 2025 | 57.32% |
| Mar 31, 2025 | 34.05% |
| Dec 31, 2024 | 24.29% |
| Sep 30, 2024 | 7.36% |
| Jun 30, 2024 | -4.42% |
| Mar 31, 2024 | 6.43% |
| Dec 31, 2023 | -15.61% |
| Sep 30, 2023 | 14.27% |
| Jun 30, 2023 | 22.25% |
| Mar 31, 2023 | 6.79% |
| Dec 31, 2022 | 69.13% |
| Sep 30, 2022 | -1.27% |
| Jun 30, 2022 | -73.50% |
| Mar 31, 2022 | -38.78% |
| Dec 31, 2021 | 67.68% |
| Sep 30, 2021 | 3.43% |
| Jun 30, 2021 | -4.01% |